People who ate broccoli one to two times a week had a 32 to 43 percent lower risk of dying from any cause during follow-up, according to a prospective cohort study published in Frontiers in Nutrition in January 2024. The researchers drew on 5,556 US adults aged 20 and older who were surveyed through NHANES between 2003 and 2006 and then tracked through December 2019.
By the end of follow-up, 1,405 participants had died, which was 25.3 percent of the sample. Cardiovascular disease was the single largest cause of death, followed by cancer.
The authors note an important limit up front. As an observational study, it "cannot demonstrate a direct causal relationship between broccoli and mortality risk reduction," and dietary intake was assessed by food frequency questionnaires, which are open to recall bias.
Where the heart benefit may come from
Broccoli belongs to the cruciferous family, alongside cabbage, kale and Brussels sprouts. According to the US National Cancer Institute, these vegetables contain glucosinolates, sulfur-based compounds that break down during chewing and digestion into bioactive molecules including sulforaphane and indole-3-carbinol.
Also read: Four lifestyle changes may slow cognitive decline in adults already at risk for Alzheimer's
Sulforaphane has been studied most intensively. A 2025 review of 84 sulforaphane clinical trials in the Journal of Nutritional Science reports that a 12-week trial in 130 participants found LDL cholesterol fell in people eating high-glucoraphanin broccoli, with the effect shaped in part by genetics.
Blood pressure results are less encouraging. The same review noted that in the single published trial, sulforaphane "did not improve hypertensive patients' blood pressure or vascular function." That is a reminder that broccoli is not a substitute for treatment when blood pressure is already high.
Blood sugar signals in trials
Sulforaphane has also been tested in people with poor blood sugar control. In one randomized trial cited by the review, broccoli sprout extract "significantly reduced fasting blood sugar and haemoglobin A1C" in overweight adults with type 2 diabetes over 12 weeks.
The picture in prediabetes is more mixed. A randomized trial in Nature Microbiology that tested broccoli sprout extract in drug-naive adults with prediabetes did not meet its primary outcome, and the average drop in fasting blood glucose across the full group was small. Anyone managing diabetes or prediabetes should discuss dietary changes with their own clinician rather than relying on a vegetable to move the numbers.
Also read: A blood test may now predict your Alzheimer's risk a full decade before symptoms
Vitamin C and the immune angle
Broccoli is one of the vegetables most often flagged for vitamin C. Harvard Health describes it as "high in vitamin A and folate (vitamin B9), as well as vitamins C and K," and notes it is a good source of potassium and dietary fiber. Vitamin C supports normal immune function and helps the body absorb non-heme iron from plant foods.
That vitamin C role in immunity is often overstated in daily life. Regular intake through food is more reliable than dosing at the first sign of a cold, an area where the evidence for prevention is thin. Welltica has covered how vitamin C does not prevent colds for most people, but daily use shortens them.
The gut and its bacteria
Broccoli also feeds the gut. Its fiber and glucosinolates reach the colon, where bacteria break them down.
A 2022 in vitro fermentation study in the journal Foods, using stool from adults with obesity, tested how sulforaphane behaves in the colon. Beneficial groups including Lactobacillus and Faecalibacterium rose in relative abundance, while potentially harmful groups such as Escherichia-Shigella and Klebsiella "drastically declined."
Also read: A daily vitamin D supplement may cut your risk of autoimmune disease by over 20%
The same experiment tracked short-chain fatty acids, molecules that fuel colon cells and are linked to metabolic health. Butyric acid rose 1.21-fold and valeric acid rose 1.46-fold after fermentation. This is a laboratory model, not a human trial, and the effects still need to be confirmed in living people.
What about cancer
The idea that broccoli helps fight cancer sits mostly in laboratory and animal work. The National Cancer Institute states that indoles and isothiocyanates have "been found to inhibit the development of cancer in several organs in rats and mice," but that studies in humans "have shown mixed results."
In other words, the mechanism is real and interesting, and the human evidence for a protective effect against specific cancers is not settled. That gap is worth keeping in mind before treating broccoli, or any single food, as a cancer shield.
A sensible reading
Read together, the evidence supports a familiar message rather than a miracle cure. A vegetable rich in vitamin C, fiber and sulforaphane, eaten one or two times a week as part of a broader diet, was associated with lower mortality in a large US cohort, and clinical trials of its most studied compound point to modest, uneven benefits for blood sugar and LDL cholesterol. That is a good reason to keep it on the plate, not a reason to skip a doctor's advice.
Also read: Combining cardio and strength training could cut your diabetes risk by half
Also read: Your cholesterol levels by age: what's normal for LDL, HDL and more
This article is made and published by Jesper Bengtson, who may have used AI in the preparation.